Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer

BACKGROUND: Biomarkers for metastatic castration-resistant prostatic cancer (mCRPC) are an unmet medical need. METHODS: The prognostic and predictive value for survival and response to salvage hormonal therapy (SHT) of baseline testosterone level (TL) was analysed in a cohort of 101 mCRPC patients p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: de Liaño, A G, Reig, O, Mellado, B, Martin, C, Rull, E U, Maroto, J P
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2014
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007243/
https://ncbi.nlm.nih.gov/pubmed/24722180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.189
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi